STUB1 and cervical cancer: In order to explore whether HPV16-miR-H1 and HPV16-miR-H6 are potential therapeutic targets for cervical cancer, we transfected SiHa cells with inhibitor-HPV16-miR-H1, inhibitor-HPV16-miR-H6, and inhibitor-NC, performed RNA-seq and CHIP-seq of enhancer marker H3K27ac, and analyzed the differentially expressed genes and H3K27ac modification changes before and after transfection (fold change > 1.5, P < 0.05).